4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.

Executive Profile*

Masato Iwasaki Ph.D.

Director and President of Japan Pharma Business Unit ,Takeda Pharmaceutical Company Limited
AgeTotal Calculated CompensationThis person is connected to 18 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Mr. Masato Iwasaki has been President of Japan Pharma Business Unit at Takeda Pharmaceutical Company Limited. Mr. Iwasaki served as Senior Vice President of Pharmaceutical Marketing Division at Takeda Pharmaceutical Company Limited since April 1, 2012. He served as Vice President of Human Resources Management Department - Pharmaceutical Marketing Division at Takeda Pharmaceutical Company Ltd. He served as Senior Vice President of Strategic Product Planning Department ...

Read Full Background

Corporate Headquarters*

12-10, Nihonbashi 2-chome
Osaka, -- 103-8668

Japan

Phone: 81 3 3278 2111
Fax: 81 3 3278 2000

Board Members Memberships*

2012-Present
Director and President of Japan Pharma Business Unit

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza Chairman, Chief Executive Officer and President
Becton, Dickinson and Company
$1.1M
Yitzhak Peterburg M.D., Dr.P.H., MSc Interim Chief Executive Officer, Interim President and Director
Teva Pharmaceutical Industries Limited
--
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Executive Director
Shire plc
$4.3M
Stefan Oschmann Chairman of Executive Board, Chief Executive Officer and Chairman of Corporate Responsibility Committee
Merck Kommanditgesellschaft auf Aktien
€5.4M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma Inc.
¥216.0M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.